ClinicalTrials.Veeva

Menu
Allied Biomedical Research Institute | Miami, FL logo

Allied Biomedical Research Institute | Miami, FL

Research site
About
Phase 1-4 Center. Neurology, Psychiatry, Rheumatology, Cardiology, Pain, Nephrology, GI and Hepatology.

Site insights

Top conditions

Top treatments

Cenerimod
RO7790121
ABBV-932
KarXT
BLI5100
Lanabecestat
ITI-1284
Gantenerumab
LY3314814
ENT-01

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Luis Estevez

Verified by this site

Active trials

26 of 70 total trials

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus (OPUS-1)

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to seve...

Active, not recruiting
Lupus Erythematosus, Systemic
Drug: Placebo
Drug: Cenerimod

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to sever...

Active, not recruiting
Lupus Erythematosus, Systemic
Drug: Cenerimod
Drug: Placebo

The goal of this clinical trial is to learn if cenerimod, on top of regular treatment, works to treat active lupus nephritis in adults with systemic...

Enrolling
Lupus Erythematosus, Systemic
Nephritis, Lupus
Drug: Placebo
Drug: Cenerimod

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

RENOIR Study: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe Rheumatoid Arthritis...

Active, not recruiting
Rheumatoid Arthritis
Drug: Placebo
Drug: Rosnilimab

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participant...

Active, not recruiting
Chronic Migraine
Drug: Placebo
Drug: Galcanezumab

The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.

Active, not recruiting
Generalized Myasthenia Gravis
Drug: Placebo
Biological: Telitacicept

Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity.Rheumatoid Arthritis (RA) is a chr...

Enrolling
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Drug: ABBV-519

This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Al...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: Placebo
Drug: KarXT

This is a Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of KarXT in male and female...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: KarXT
Drug: Placebo

This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of Afimkibart (RO7790121) co...

Active, not recruiting
Moderately to Severely Active Ulcerative Colitis
Drug: Afimkibart
Drug: Placebo

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO779...

Active, not recruiting
Moderately to Severely Active Ulcerative Colitis
Drug: Afimkibart
Drug: Placebo

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also...

Enrolling
Moderately to Severely Active Crohns Disease
Drug: Placebo
Drug: Afimkibart

This is a multicenter, randomized, double-blind, placebo-controlled, flexible-dose study of the efficacy, safety, and tolerability of ITI-1284 in pat...

Enrolling
Agitation Associated With Alzheimer's Dementia
Drug: Placebo
Drug: ITI-1284

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the efficacy, safety, and tolerab...

Enrolling
Alzheimer Disease
Psychotic Disorders
Drug: Placebo
Drug: ITI-1284

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Placebo

A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease. The study will consist of a 4...

Enrolling
Parkinson Disease
Drug: BHV-8000 10mg
Drug: Placebo

Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate th...

Enrolling
Rheumatoid Arthritis
Drug: Lutikizumab
Drug: Placebo

The purpose of this study is to evaluate the disease-drug-drug interaction (DDDI) potential of afimkibart (also known as RO7790121). This will be ass...

Enrolling
Active Ulcerative Colitis
Drug: Afimkibart
Drug: Midazolam

The goal of this clinical study is to learn about the long-term safety and tolerability of cenerimod in adult patients with moderate to severe sympto...

Invitation-only
Lupus Erythematosus, Systemic
Drug: Cenerimod

Trial sponsors

AbbVie logo
Roche logo
Otsuka logo
V
Intra-Cellular Therapies logo
K
AstraZeneca logo
Braintree Laboratories logo
E
LG Chem logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems